Literature DB >> 8316880

Magnetic resonance imaging of the discs and trunk muscles in patients with chronic low back pain and healthy control subjects.

R Parkkola1, U Rytökoski, M Kormano.   

Abstract

This study aimed to evaluate the lumbar intervertebral discs and the maximum isometric strength and size of the trunk muscles of middle-aged healthy volunteers (60 persons) and low back pain patients (48 persons). Disc degeneration was more frequently seen in the patients than in the healthy volunteers. The psoas and back muscles (erector spinae and multifidus) of the patients were smaller than those of the volunteers. Patients had also more fat deposits in the back muscles than controls. The maximum isometric strength of trunk muscles of the patients was on average weaker than that of the volunteers. However, the size of the back muscles was not related to the maximum isometric extension strength of the trunk.

Entities:  

Mesh:

Year:  1993        PMID: 8316880     DOI: 10.1097/00007632-199306000-00004

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  86 in total

1.  Effects of three different training modalities on the cross sectional area of the lumbar multifidus muscle in patients with chronic low back pain.

Authors:  L A Danneels; G G Vanderstraeten; D C Cambier; E E Witvrouw; J Bourgois; W Dankaerts; H J De Cuyper
Journal:  Br J Sports Med       Date:  2001-06       Impact factor: 13.800

2.  Changes in the cross-sectional area of multifidus and psoas in unilateral sciatica caused by lumbar disc herniation.

Authors:  Wook Ha Kim; Sang-Ho Lee; Dong Yeob Lee
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

3.  Volume and fat infiltration of spino-pelvic musculature in adults with spinal deformity.

Authors:  Bertrand Moal; Nicolas Bronsard; José G Raya; Jean Marc Vital; Frank Schwab; Wafa Skalli; Virginie Lafage
Journal:  World J Orthop       Date:  2015-10-18

Review 4.  Exercise in the management of chronic back pain.

Authors:  Thomas E Dreisinger
Journal:  Ochsner J       Date:  2014

5.  No correlation between patient outcome and abnormal lumbar MRI findings 21 years after posterior or posterolateral fusion for isthmic spondylolisthesis in children and adolescents.

Authors:  Ville M Remes; Tommi S Lamberg; Pekka O Tervahartiala; Ilkka J Helenius; Kalevi Osterman; Dietrich Schlenzka; Timo Yrjönen; Seppo Seitsalo; Mikko S Poussa
Journal:  Eur Spine J       Date:  2005-09-07       Impact factor: 3.134

6.  The location of multifidus atrophy in patients with a single level, unilateral lumbar radiculopathy.

Authors:  Jung-Il Kang; Sun-Yu Kim; Jin-Hyun Kim; Hyun Bang; In-Sik Lee
Journal:  Ann Rehabil Med       Date:  2013-08-26

7.  An investigation into the use of MR imaging to determine the functional cross sectional area of lumbar paraspinal muscles.

Authors:  Craig A Ranson; Angus F Burnett; Robert Kerslake; Mark E Batt; Peter B O'Sullivan
Journal:  Eur Spine J       Date:  2005-05-14       Impact factor: 3.134

8.  Direct repair for treatment of symptomatic spondylolysis and low-grade isthmic spondylolisthesis in young patients: no benefit in comparison to segmental fusion after a mean follow-up of 14.8 years.

Authors:  Dietrich Schlenzka; Ville Remes; Ilkka Helenius; Tommi Lamberg; Pekka Tervahartiala; Timo Yrjönen; Kaj Tallroth; Kalevi Osterman; Seppo Seitsalo; Mikko Poussa
Journal:  Eur Spine J       Date:  2006-02-07       Impact factor: 3.134

9.  Architectural analysis and intraoperative measurements demonstrate the unique design of the multifidus muscle for lumbar spine stability.

Authors:  Samuel R Ward; Choll W Kim; Carolyn M Eng; Lionel J Gottschalk; Akihito Tomiya; Steven R Garfin; Richard L Lieber
Journal:  J Bone Joint Surg Am       Date:  2009-01       Impact factor: 5.284

10.  Whole-body MRI in adult inflammatory myopathies: Do we need imaging of the trunk?

Authors:  Lukas Filli; Britta Maurer; Andrei Manoliu; Gustav Andreisek; Roman Guggenberger
Journal:  Eur Radiol       Date:  2015-04-24       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.